Triple-negative breast tumors are dependent on mutant p53 for growth and survival
Proceedings of the National Academy of Sciences · 22.08.2023 · 120 (34)
DOI: 10.1073/pnas.2308807120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 14.08.2023. Verfasst von Denada Dibra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, HHS | NIH | National Cancer Institute, EIF | Stand Up To Cancer.
Abstract (Originalsprache)
The TP53 tumor suppressor gene is mutated early in the majority of patients with triple-negative breast cancer (TNBC). The most frequent TP53 alterations are missense mutations that contribute to tumor aggressiveness. We developed an autochthonous somatic K14-Cre driven TNBC mouse model with p53R172H and p53R245W mutations in which mutant p53 can be toggled on and off genetically while leaving the tumor microenvironment intact and wild-type for p53. These mice develop TNBCs with a median latency of 1 y. Deletion of mutant p53R172H or p53R245W in vivo in these tumors blunts their tumor growth and significantly extends survival of mice. Downstream analyses revealed that deletion of mutant Trp53 activated the cyclic GMP–AMP Synthase–Stimulator of Interferon Genes pathway but did not cause apoptosis implicating other mechanisms of tumor regression. Furthermore, we determined that only tumors with stable mutant p53 are dependent on mutant p53 for growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
- Genetics and Epigenetics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030.
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
- Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
ORCID-Profile: Yuan Qi, Guillermina Lozano
Förderung
- NCI NIH HHS
- HHS | NIH | National Cancer Institute
- EIF | Stand Up To Cancer
Zitieren
APA
Dibra, D., Moyer, S. M., El-Naggar, A. K., Qi, Y., Su, X., & Lozano, G. (2023). Triple-negative breast tumors are dependent on mutant p53 for growth and survival. Proceedings of the National Academy of Sciences, 120(34). https://doi.org/10.1073/pnas.2308807120
Vancouver
Dibra D, Moyer SM, El-Naggar AK, Qi Y, Su X, Lozano G. Triple-negative breast tumors are dependent on mutant p53 for growth and survival. Proceedings of the National Academy of Sciences. 2023;120(34). doi:10.1073/pnas.2308807120
BibTeX
@article{Dibra2023,
author = {Dibra, Denada and Moyer, Sydney M and El-Naggar, Adel K and Qi, Yuan and Su, Xiaoping and Lozano, Guillermina},
title = {Triple-negative breast tumors are dependent on mutant p53 for growth and survival},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {34},
doi = {10.1073/pnas.2308807120}
}
EUVIMED